​

Cibus Stock (NASDAQ:CBUS)

ForecastRevenueOwnershipFinancialsChartTranscripts
Cibus by TradingView

Previous Close

$1.50

52W Range

$1.09 - $4.19

50D Avg

$2.56

200D Avg

$1.81

Market Cap

$67.78M

Avg Vol (3M)

$650.77K

Beta

1.93

Div Yield

-

CBUS Company Profile

Cibus, Inc., a agricultural technology company, develops and licenses plant traits to seed companies for royalties. The company primarily focus on trait productivity in two areas, including productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients that enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases. The company is based in San Diego, California.

Show More

Industry

Biotechnology

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

157

IPO Date

Jul 20, 2017

Website

CBUS Performance

Revenue Breakdown

Revenue Breakdown by Product/Service

Product/ServiceDec 25Dec 24
Reportable Segment$3.64M$4.26M

Fiscal year ends in Dec 25 | Currency in USD

CBUS Financial Summary

Dec 25Dec 24Dec 23
Revenue$3.64M$4.26M$1.82M
Operating Income$-97.53M$-258.40M$-318.88M
Net Income$-127.08M$-251.39M$-267.63M
EBITDA$-97.53M$-241.63M$-314.58M
Basic EPS$-2.78$-10.83$-25.95
Diluted EPS$-2.78$-10.83$-25.95

Fiscal year ends in Dec 25 | Currency in USD

Latest Earnings Call Transcripts

Q4 25Mar 17, 26 | 4:30 PM
Q3 25Nov 13, 25 | 4:30 PM
Q2 25Aug 15, 25 | 4:30 PM

Peer Comparison

TickerCompany
MNOVMediciNova, Inc.
CAMPCAMP4 Therapeutics Corporation
RPTXRepare Therapeutics Inc.
PMVPPMV Pharmaceuticals, Inc.
BMEABiomea Fusion, Inc.
ACRVAcrivon Therapeutics, Inc. Common Stock
IMUXImmunic, Inc.
RLMDRelmada Therapeutics, Inc.
VXRTVaxart, Inc.
UNCYUnicycive Therapeutics, Inc.